Uncovering performance incentives that can lead to corporate fraud

 
1 Nate Raymond, “Mylan, U.S. finalize $465 million EpiPen settlement,” Reuters, August 17, 2017, https://reut.rs/2JjTPU1.


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field